Operating Lease, Right-of-Use Asset of ICU MEDICAL INC/DE from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ICU MEDICAL INC/DE quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • ICU MEDICAL INC/DE Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $54,470,000, a 2.2% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ICU MEDICAL INC/DE Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $54,470,000 +$1,175,000 +2.2% 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q3 2025 $56,598,000 -$3,159,000 -5.3% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $58,888,000 -$7,520,000 -11% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $58,025,000 -$6,903,000 -11% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $53,295,000 -$16,614,000 -24% 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q3 2024 $59,757,000 -$14,010,000 -19% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $66,408,000 -$9,620,000 -13% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $64,928,000 -$14,808,000 -19% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $69,909,000 -$4,955,000 -6.6% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $73,767,000 -$2,671,000 -3.5% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $76,028,000 -$7,295,000 -8.8% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $79,736,000 -$12,291,000 -13% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $74,864,000 +$35,017,000 +88% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $76,438,000 +$35,459,000 +87% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $83,323,000 +$40,008,000 +92% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $92,027,000 +$46,768,000 +103% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $39,847,000 -$6,724,000 -14% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $40,979,000 -$6,823,000 -14% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $43,315,000 -$6,397,000 -13% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q1
Q1 2021 $45,259,000 -$5,171,000 -10% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $46,571,000 +$12,106,000 +35% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $47,802,000 +$12,015,000 +34% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $49,712,000 +$12,925,000 +35% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $50,430,000 +$15,965,000 +46% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $34,465,000 +$34,465,000 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $35,787,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $36,787,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $34,465,000 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $0 31 Dec 2018 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.